Early Clinical Outcomes of the First Commercialized Human Autologous Ex Vivo Cultivated Oral Mucosal Epithelial Cell Transplantation for Limbal Stem Cell Deficiency: Two Case Reports and Literature Review

The first product in the world for ex vivo cultivated oral mucosal epithelial cell transplantation (COMET) to treat limbal stem cell deficiency (LSCD), named Ocural(®), was launched in June 2021 in Japan. COMET was performed on two patients, including the first case in the post-marketing phase of Oc...

Descripción completa

Detalles Bibliográficos
Autores principales: Toshida, Hiroshi, Kasahara, Tomoto, Kiriyama, Masamichi, Iwasaki, Yuma, Sugita, Jobu, Ichikawa, Kohei, Ohta, Toshihiko, Miyahara, Katsumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10219018/
https://www.ncbi.nlm.nih.gov/pubmed/37240280
http://dx.doi.org/10.3390/ijms24108926

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10219018/
https://www.ncbi.nlm.nih.gov/pubmed/37240280
http://dx.doi.org/10.3390/ijms24108926

Ejemplares similares